December 1, 2016 - By Darrin Black · 0 Comments
The stock of Dynatronics Corporation (NASDAQ:DYNT) registered an increase of 212.24% in short interest. DYNT’s total short interest was 15,300 shares in December as published by FINRA. Its up 212.24% from 4,900 shares, reported previously. With 12,000 shares average volume, it will take short sellers 1 days to cover their DYNT’s short positions. The short interest to Dynatronics Corporation’s float is 0.8%. About 2,138 shares traded hands. Dynatronics Corporation (NASDAQ:DYNT) has declined 11.46% since April 28, 2016 and is downtrending. It has underperformed by 17.38% the S&P500.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The company has a market cap of $7.07 million. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. It currently has negative earnings. The Company’s products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Insitutional Activity: The institutional sentiment increased to 4 in Q2 2016. Its up 3.00, from 1 in 2016Q1. The ratio is positive, as 1 funds sold all Dynatronics Corporation shares owned while 1 reduced positions. 1 funds bought stakes while 1 increased positions. They now own 177,361 shares or 0.03% more from 177,305 shares in 2016Q1.
Perritt last reported 0.05% of its portfolio in the stock. Blackrock Institutional Tru Na, a California-based fund reported 22,786 shares. Citigroup has 0% invested in the company for 8,335 shares. Tower Research Capital Limited Liability Corporation (Trc) reported 886 shares or 0% of all its holdings. Bank Of America De, a North Carolina-based fund reported 20,007 shares.
Dynatronics Corporation, incorporated on April 29, 1983, is a maker and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. The Company’s products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. The Company’s physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy, ultrasound, phototherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including motorized and stationary treatment tables, parallel bars, traction systems and wood furniture; manufactured supplies, including hot pack and covers, cold packs, braces, belts, wraps, straps, pillow and cushions, wedges, bolsters and mats; distributed capital products, including hydrotherapy, exercise equipment, weight training equipment and pilates, and distributed supplies, including clinical accessories, aids to daily living, exercise balls and bands, sports med and taping products, lotions and gels.
More notable recent Dynatronics Corporation (NASDAQ:DYNT) news were published by: Prnewswire.com which released: “Dynatronics Corporation Names Tyler Oglesby Director of Post-Acute Care Sales …” on January 11, 2016, also Prnewswire.com with their article: “Dynatronics Schedules Conference Call to Report Financial Results for First …” published on November 11, 2016, Prnewswire.com published: “Dynatronics Announces 10% increase in Top Line Sales for Fiscal 2017 First Quarter” on November 14, 2016. More interesting news about Dynatronics Corporation (NASDAQ:DYNT) were released by: Prnewswire.com and their article: “Dynatronics Releases its Latest Stand Alone Ultrasound, the Dynatron® 125B” published on September 20, 2016 as well as Prnewswire.com‘s news article titled: “Dynatronics Strengthens Sales Organization Leadership” with publication date: March 02, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black